Rating History for Madrigal Pharmaceuticals (MDGL) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for MDGL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/27/2026 N/A New Coverage Overweight
(N/A)		 685.00
(N/A)		 544.51
(538.71)		 -1.07% Details